Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Raderer

Showing results (91-100 of 264) with videos related to

Pageof 27
Sort By:
In Vivo (Athens, Greece)|January 6, 2021
Adolescents and Young Adults (AYAs) With Initially Localized and Metastatic Bone Sarcomas: A Retrospective Single Center Analysis of Side Effect ManagementChristoph Minichsdorfer, Oskar Steinbrecher, Marita KÖlz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
High relapse rate in patients with MALT lymphoma warrants lifelong follow-upMarkus Raderer, Berthold Streubel, Stefan Woehrer, et al.
Digestion|September 20, 2002
Comparison of spiral-computed tomography with water-filling of the stomach and endosonography for gastric lymphoma of mucosa-associated lymphoid tissue-typeFriedrich Vorbeck, Christian Osterreicher, Andreas Püspök, et al.
Oncology|April 22, 2015
Allogeneic Hematopoietic Stem Cell Transplantation in Mantle Cell Lymphoma: A Retrospective Analysis of 7 PatientsWolfgang Lamm, Philipp Wohlfarth, Marija Bojic, et al.
Annals of Hematology|April 27, 2011
Second line chemotherapy in patients with enteropathy-associated T cell lymphoma: a retrospective single center analysisMarkus Raderer, Marlene Troch, Barbara Kiesewetter, et al.
Annals of Hematology|August 9, 2013
Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)Barbara Kiesewetter, Marius E Mayerhoefer, Julius Lukas, et al.
Hematological Oncology|July 9, 2019
Prolonged follow-up on lenalidomide-based treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma)-Real-world data from the Medical University of ViennaBarbara Kiesewetter, Wolfgang Lamm, Ortrun Neuper, et al.
Oncology|January 21, 2006
Rituximab, Ara-C, dexamethasone and oxaliplatin is safe and active in heavily pretreated patients with diffuse large B-cell lymphomaStefan Woehrer, Michael Hejna, Cathrin Skrabs, et al.
Anticancer Research|February 6, 2009
The combination of 5-fluorouracil, leukovorin, etoposide, and cisplatin (FLEP) in patients with metastatic esophageal cancer. A single-institution experienceConstanze Jonak, Markus Raderer, Johannes Zacherl, et al.
Scientific Reports|September 17, 2021
Azithromycin concentrations during long-term regimen, a pilot study in patients with MALT lymphomaRaphael Scheibenpflug, Markus Obermüller, Gottfried Reznicek, et al.
Pageof 27

Showing results (91-100 of 264) with videos related to

Sort By:
Pageof 27
In Vivo (Athens, Greece)|January 6, 2021
Adolescents and Young Adults (AYAs) With Initially Localized and Metastatic Bone Sarcomas: A Retrospective Single Center Analysis of Side Effect ManagementChristoph Minichsdorfer, Oskar Steinbrecher, Marita KÖlz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
High relapse rate in patients with MALT lymphoma warrants lifelong follow-upMarkus Raderer, Berthold Streubel, Stefan Woehrer, et al.
Digestion|September 20, 2002
Comparison of spiral-computed tomography with water-filling of the stomach and endosonography for gastric lymphoma of mucosa-associated lymphoid tissue-typeFriedrich Vorbeck, Christian Osterreicher, Andreas Püspök, et al.
Oncology|April 22, 2015
Allogeneic Hematopoietic Stem Cell Transplantation in Mantle Cell Lymphoma: A Retrospective Analysis of 7 PatientsWolfgang Lamm, Philipp Wohlfarth, Marija Bojic, et al.
Annals of Hematology|April 27, 2011
Second line chemotherapy in patients with enteropathy-associated T cell lymphoma: a retrospective single center analysisMarkus Raderer, Marlene Troch, Barbara Kiesewetter, et al.
Annals of Hematology|August 9, 2013
Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)Barbara Kiesewetter, Marius E Mayerhoefer, Julius Lukas, et al.
Hematological Oncology|July 9, 2019
Prolonged follow-up on lenalidomide-based treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma)-Real-world data from the Medical University of ViennaBarbara Kiesewetter, Wolfgang Lamm, Ortrun Neuper, et al.
Oncology|January 21, 2006
Rituximab, Ara-C, dexamethasone and oxaliplatin is safe and active in heavily pretreated patients with diffuse large B-cell lymphomaStefan Woehrer, Michael Hejna, Cathrin Skrabs, et al.
Anticancer Research|February 6, 2009
The combination of 5-fluorouracil, leukovorin, etoposide, and cisplatin (FLEP) in patients with metastatic esophageal cancer. A single-institution experienceConstanze Jonak, Markus Raderer, Johannes Zacherl, et al.
Scientific Reports|September 17, 2021
Azithromycin concentrations during long-term regimen, a pilot study in patients with MALT lymphomaRaphael Scheibenpflug, Markus Obermüller, Gottfried Reznicek, et al.
Pageof 27